Xaira Therapeutics
Xaira Therapeutics

Xaira Therapeutics

DR44Ahrefs DR: 44/100. Above median. Measured by Ahrefs. Median 44.Agent40Agent Readiness: 40/100. Below median. Measured by StartupHub.ai. Median 41.

AI-powered biotech platform using protein design to discover novel therapeutic molecules for hard-to-treat targets.

2024ActiveSan Francisco, United States

About

Xaira Therapeutics is an AI-powered biotechnology company pioneering transformative artificial intelligence to discover and develop next-generation medicines. Their core product, X-Cell, is a virtual cell model and the largest causal perturbation model built to date, designed to accurately predict the outcomes of genetic perturbations. This technology aims to transform drug discovery into a predictive engineering discipline, ultimately delivering a pipeline of new medicines to patients.

Key facts

At-a-glance profile data

Website
xaira.com
Headquarters
San Francisco, United States
Founded
2024
Total funding
-
Business model
B2B

Tech stack

Detected on xaira.com, last scanned 13 Sept 2026. Run your own scan

CMS / Builders
Webflow
CDN
Cloudflare
Email provider
Google Workspace
Cookie consent
OneTrust
Add first review